๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Consensus review of the clinical utility of dna content cytometry in prostate cancer

โœ Scribed by T. Vincent Shankey; Ollie-Pekka Kallioniemi; James M. Koslowski; Michael L. Lieber; Brian H. Mayall; Gary Miller; Gary J. Smith


Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
485 KB
Volume
14
Category
Article
ISSN
0196-4763

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Diagnostic utility of DNA content flow c
โœ Seth P. Harlow; Rosemary B. Duda; Kenneth D. Bauer ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 444 KB

## Abstract Preoperative diagnosis of follicular carcinoma of the thyroid remains a clinical challenge. This study determined the DNA content parameters of ploidy and proliferative activity levels from cells of normal thyroid tissue, follicular adenomas, and follicular carcinomas to evaluate if the

The prognostic significance of nuclear d
โœ Gun Forsslund; Pier-Luigi Esposti; Bo Nilsson; Anders Zetterberg ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 684 KB

The prognostic significance of ploidy level was studied in prostatic carcinoma and compared with the prognostic significance of morphologic grade and clinical stage. A nonselected group of 145 patients was studied in whom prostatic carcinoma was diagnosed by fine-needle aspiration biopsy at the Karo

Clinical utility of apparent diffusion c
โœ Yasushi Itou; Katsuyuki Nakanishi; Yoshifumi Narumi; Yasuko Nishizawa; Hideaki T ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 427 KB ๐Ÿ‘ 1 views

## Abstract ## Purpose To retrospectively evaluate the relationship between apparent diffusion coefficient (ADC) values and Gleason score (GS) in prostate cancer. ## Methods A total of 60 patients who underwent radical prostatectomy for clinically localized prostate cancer were selected for this

Bicalutamide (Casodexยฎ) in the treatment
โœ Kolvenbag, Geert J.C.M.; Blackledge, George R.P.; Gotting-Smith, Karen ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 170 KB ๐Ÿ‘ 1 views

BACKGROUND. Bicalutamide (Casodex) is a new nonsteroidal antiandrogen developed for use in patients with prostate cancer. The efficacy and tolerability of bicalutamide as monotherapy and as combination therapy for patients with advanced prostate cancer have been evaluated in randomized clinical tria